Next-Generation Antibody Market Competitor Strategy and Trends by Forecast to 2028

The Next-Generation Antibody Industry report provides a basic overview of the market including definitions, classifications, applications and industry chain structure. The Next-Generation Antibody Market analysis is provided for the international market including development history, competitive landscape analysis and major regions' development status.

Download PDF Sample Copy at:
https://www.theinsightpartners.com/sample/TIPRE00006412/?utm_source=OpenPR&utm_medium=10376

According to our new research study on "Next-Generation Antibody Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Therapeutic Area, and Technology," the market is expected to reach US$ 12,050.13 million by 2028 from US$ 5,468.41 million in 2021; it is estimated to grow at a CAGR of 11.9% during 2021-2028. The report highlights trends prevailing in the market and factors driving its growth. The growth of the market is attributed to the rising prevalence of cancer worldwide and the increasing demand for next-generation antibody. However, the complications associated with manufacturing and approvals hamper the market growth.

Based on therapeutic area, the next-generation antibody market is bifurcated into oncology and autoimmune/inflammatory. The oncology segment held a larger share of the market in 2021. The same segment is anticipated to register a higher CAGR in the market during the forecast period due to the vast usage of next-generation antibody for cancers, high volume consumption, and product innovation for this field.

Have a Call with Analyst:
https://www.theinsightpartners.com/speak-to-analyst/TIPRE00006412/?utm_source=OpenPR&utm_medium=10376

Impact of COVID-19 Pandemic on Next-Generation Antibody Market

The COVID-19 pandemic is adversely affecting industries worldwide. The outbreak led to significant disruptions in primary industries, such as manufacturing, healthcare, energy & power, electronics & semiconductor, aerospace & defense, and construction in 2020. In the initial days of the COVID-19 outbreak, many sectors witnessed a negative impact on the total sales of most companies. The approval of monoclonal antibody services has expanded for the development of COVID-19 vaccines. The companies engaging in the next-generation antibody market witnessed a negative impact on their services in early 2020 due to the temporary shutdown of their laboratories. However, as lockdown limitations were gradually lifted, research laboratories across the world started reopening. As a result, most service providers prioritized actions to promote the critical work of consumers included in COVID-19 infection, such as giving a range of high-quality COVID-19 related research tools; reassigning R&D resources for producing essential products for SARS-Cov-2; expanding the supply chain; making flexibility to support expanded demand for enduring products applied for COVID-19 research; and entering into discussions and collaborations across the UK, US, and China concentrated on SARS-CoV-2 diagnostics, drugs, and vaccines development. Considering these, the impact of the COVID-19 pandemic on the next-generation antibody market has been positive.

Top Players:

F. HOFFMANN-LA ROCHE LTD.; Kyowa Kirin Co., Ltd.; Seagen Inc.; ImmunoGen, Inc.; Takeda Pharmaceutical Company Limited; Amgen Inc.; Pfizer Inc.; Catalent Inc; AstraZeneca; and Xencor are among the leading companies operating in the next-generation antibody market.

Buy Report at:
https://www.theinsightpartners.com/buy/TIPRE00006412/?utm_source=OpenPR&utm_medium=10376

Contact us:

If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-987

About The Insight Partners:

The Insight Partners is a one top industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Manufacturing and Construction, Technology, Chemicals and Materials.
We offer our clients multiple ways to customize research as per their specific needs and budget.

This release was published on openPR.